DETAILS
Gemcitabine is a chemotherapy medication used to treat a number of types of cancer. These cancers include breast
cancer, ovarian cancer, non-small cell lung cancer, pancreatic cancer, and bladder cancer.
Suitable for the treatment of inoperable advanced or metastatic pancreatic cancer and the treatment of locally advanced or metastatic non-small cell lung cancer, and the treatment for mid-term and advanced non-small cell lung cancer, non-small cell lung cancer, pancreatic cancer, bladder cancer, breast cancer and other solid tumors.
| Product name | Gemcitabine hydrochloride |
| CAS | 95058-81-4 |
| Molecular formula | C9H12ClF2N3O4 |
| Molecular weight | 299.66 |
| EINECS | 601-823-3 |
| Melting point | >250°C dec. |
| Storage | Desiccate at +4°C |
| Appearance | White powder |
For the treatment of inoperable advanced or metastatic pancreatic cancer and the treatment of locally advanced or
metastatic non-small cell lung cancer, treatment of advanced non-small cell lung cancer, non-small cell lung cancer,
pancreatic cancer, bladder cancer, breast cancer and other entities tumors.
Gemcitabine hydrochloride/Gemcitabine HCL is used in various carcinomas: non-small cell lung cancer, pancreatic
cancer, bladder cancer and breast cancer. Gemcitabine HCL is being investigated for use in esophageal cancer, and
is used experimentally in lymphomas and various other tumor types. Gemcitabine HCL represents an advance in
pancreatic cancer care. Gemcitabine HCL is also not as debilitating as some other forms of chemotherapy.
